Position in CRVO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$251,781
-$448,040 QoQ
Shares Held
63,904
+33.3% QoQ
Ownership
0.423%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in CRVO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $251,781 | 63,904 | Shares | Sole | 2026-05-14 | |
| 2024-09-30 | $699,821 | 47,933 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $553,540 | 32,333 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $716,078 | 30,733 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $221,521 | 29,033 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $135,056 | 29,233 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 DFFN | — | 40,309 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 DFFN | — | 39,109 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 DFFN | — | 38,809 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 DFFN | — | 44,009 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 DFFN | — | 48,773 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||